Walgreens Boots Alliance Declares Regular Quarterly Dividend

DEERFIELD, Ill.–(BUSINESS WIRE)–Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced that its
board of directors has declared a regular quarterly dividend of 37.5
cents per share, an increase of 4.2 percent over the year-ago period.
The dividend is payable 12 December 2016 to stockholders of record as of
17 November 2016.

Walgreens Boots Alliance and its predecessor company, Walgreen Co., have
paid a dividend in 336 straight quarters (or 84 years) and have raised
the dividend for 41 consecutive years.

Notes to Editors:

About Walgreens Boots Alliance

Walgreens Boots Alliance (Nasdaq: WBA) is the first global pharmacy-led,
health and wellbeing enterprise.

The company was created through the combination of Walgreens and
Alliance Boots in December 2014, bringing together two leading companies
with iconic brands, complementary geographic footprints, shared values
and a heritage of trusted health care services through pharmaceutical
wholesaling and community pharmacy care, dating back more than 100 years.

Walgreens Boots Alliance is the largest retail pharmacy, health and
daily living destination in the USA and Europe and, together with its
equity method investments*, employs more than 370,000* people and has a
presence in more than 25* countries. Walgreens Boots Alliance is a
global leader in pharmacy-led, health and wellbeing retail with over
13,100* stores in 11* countries. The company includes one of the largest
global pharmaceutical wholesale and distribution networks with over 350*
distribution centers delivering to more than 200,000** pharmacies,
doctors, health centers and hospitals each year in 19* countries. In
addition, Walgreens Boots Alliance is one of the world’s largest
purchasers of prescription drugs and many other health and wellbeing
products.

The company’s portfolio of retail and business brands includes
Walgreens, Duane Reade, Boots and Alliance Healthcare, as well as
increasingly global health and beauty product brands, such as No7,
Botanics, Liz Earle and Soap & Glory. More company information is
available at www.walgreensbootsalliance.com.

* As at 31 August 2015 (without subsequent adjustment for business
acquisitions or dispositions), including equity method investments

** For 12 months ended 31 August 2015 (without subsequent adjustment
for business acquisitions or dispositions), including equity method
investments

(WBA-DIV)

Cautionary Note Regarding Forward-Looking Statements: All statements
in this release that are not historical are forward-looking statements
made pursuant to the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. These forward-looking statements are not
guarantees of future performance and involve risks, assumptions and
uncertainties, including those described in Item 1A (Risk Factors) of
our Form 10-K for the fiscal year ending 31 August 2015 and our
Quarterly Report on Form 10-Q for the fiscal quarter ended 31 May 2016,
each of which is incorporated herein by reference, and in other
documents that we file or furnish with the Securities and Exchange
Commission. Should one or more of these risks or uncertainties
materialize, or should underlying assumptions prove incorrect, actual
results may vary materially. These forward-looking statements speak only
as of the date they are made. Except to the extent required by law, we
do not undertake, and expressly disclaim, any duty or obligation to
update publicly any forward-looking statement after the date of this
release, whether as a result of new information, future events, changes
in assumptions or otherwise.

Contacts

Walgreens Boots Alliance, Inc.
Media Relations
USA /
Michael Polzin
+1 847 315 2935
or
International / Laura
Vergani
+44 (0)207 980 8585
or
Investor Relations
Gerald
Gradwell and Ashish Kohli
+1 847 315 2922